Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study

被引:12
|
作者
Aitken, Clare A. [1 ,2 ]
Inturrisi, Federica [3 ,4 ]
Kaljouw, Sylvia [1 ]
Nieboer, Daan [1 ]
Siebers, Albert G. [5 ]
Melchers, Willem J. G. [6 ]
van den Brule, Adriaan J. C. [7 ]
Molijn, Anco [8 ]
Hinrichs, John W. J. [9 ,10 ]
Niesters, Hubert G. M. [11 ]
van Kemenade, Folkert J. [2 ]
Berkhof, Johannes
de Kok, Inge M. C. M. [1 ,12 ]
机构
[1] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands
[2] Erasmus MC, Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands
[3] Vrije Univ Amsterdam, Epidemiol & Data Sci, Amsterdam UMC locat, Amsterdam, Netherlands
[4] Amsterdam Publ Hlth, Methodol, Amsterdam, Netherlands
[5] PALGA Fdn, Nationwide Network & Registry Histo & Cytopathol N, Houten, Netherlands
[6] Radboud Univ Nijmegen, Med Microbiol, Med Ctr, Nijmegen, Netherlands
[7] Jeroen Bosch Hosp, Pathologie DNA, sHertogenbosch, Netherlands
[8] NMDL LCPL, DDL Diagnost Lab, Rijswijk, Netherlands
[9] Symbiant Pathol Expert Ctr Hoorn, Hoorn, Netherlands
[10] Univ Med Ctr Utrecht, Pathol, Utrecht, Netherlands
[11] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Div Clin Virol, Groningen, Netherlands
[12] Erasmus MC, Univ Med Ctr Rotterdam, Univ Med Ctr, Publ Hlth, NL-3000 CA Rotterdam, Netherlands
关键词
COLLABORATIVE REANALYSIS; INDIVIDUAL DATA; NON-ATTENDEES; RISK; SMOKING;
D O I
10.1158/1055-9965.EPI-22-0712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In the Netherlands, lower high-risk human pap-illomavirus (hrHPV) positivity but higher cervical intraepithelial neoplasia (CIN) 2+ detection were found in self-collected com-pared with clinician-collected samples. To investigate the possible reason for these differences, we compared sociodemographic and screening characteristics of women and related these to screening outcomes.Methods: We extracted data from PALGA on all primary hrHPV screens and associated follow-up tests for 857,866 screened women, invited in 2017 and 2018. We linked these data with sociodemo-graphic data from Statistics Netherlands. Logistic regression was performed for hrHPV positivity and CIN 2+/3+ detection.Results: Out of the 857,866 women, 6.8% chose to use a self-sampling device. A higher proportion of self-sampling users was ages 30 to 35 years, was not previously screened, was living in a one-person household, or was the breadwinner in the household. After adjustment for these factors self-sampling had lower hrHPV positivity (aOR, 0.65; 95% CI, 0.63-0.68)) as compared with clini-cian-collected sampling, as well as lower odds of CIN 2+ (aOR, 0.76; 95% CI, 0.70-0.82) and CIN 3+ (aOR, 0.86; 95% CI, 0.78-0.95) detection.Conclusions: It is likely that the observed differences between the two sampling methods are not only related to sociodemographic differences, but related to differences in screening test accuracy and/ or background risk.Impact: Self-sampling can be used for targeting underscreened women, as a more convenient screening tool. Further investigation is required to evaluate how to implement self-sampling, when it is used as a primary instrument in routine screening.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 50 条
  • [1] POTENTIAL OF HRHPV SELF-SAMPLING DETECTION IN THE DUTCH CERVICAL SCREENING POPULATION, THE VERA TRIAL
    Ketelaars, P. J. W.
    Bosgraaf, R. P.
    Massuger, L. F. A. G.
    Siebers, A. G.
    van der Linden, H. J. C.
    Wauters, C. A.
    Rahamat-Langendoen, J. C.
    van den Brule, A. J. C.
    Melchers, W. J. G.
    Bekkers, R. L. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 46 - 47
  • [2] EXPERIENCES OF WOMEN PARTICIPANTS IN CERVICAL CANCER SCREENING WITH SELF-SAMPLING IN CATALONIA: A QUALITATIVE STUDY
    Peremiquel-Trillas, P.
    Rangel, V.
    Torrecilla, I.
    Carvajal, M.
    Robles, C.
    Ibanez, R.
    Espinas, J. A.
    Bruni, L.
    Prades, J.
    GACETA SANITARIA, 2023, 37 : S27 - S28
  • [3] Evaluation of the self-sampling for cervical cancer screening in Bolivia
    Gustavo Allende
    Pedro Surriabre
    Leyddy Cáceres
    Diego Bellot
    Neli Ovando
    Andrea Torrico
    Pamela Calle
    Carla Ascarrunz
    Sophie Alexander
    Michel Bossens
    Véronique Fontaine
    Patricia Rodríguez
    BMC Public Health, 19
  • [5] Evaluation of the self-sampling for cervical cancer screening in Bolivia
    Allende, Gustavo
    Surriabre, Pedro
    Caceres, Leyddy
    Bellot, Diego
    Ovando, Neli
    Torrico, Andrea
    Calle, Pamela
    Ascarrunz, Carla
    Alexander, Sophie
    Bossens, Michel
    Fontaine, Veronique
    Rodriguez, Patricia
    BMC PUBLIC HEALTH, 2019, 19 (1)
  • [6] Diagnoses and outcomes in cervical cancer screening: A population-based study
    Insinga, RP
    Glass, AG
    Rush, BB
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (01) : 105 - 113
  • [7] Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women
    Bosgraaf, Remko P.
    Ketelaars, Pleun J. W.
    Verhoef, Viola M. J.
    Massuger, Leon F. A. G.
    Meijer, Chris J. L. M.
    Melchers, Willem J. G.
    Bekkers, Ruud L. M.
    PREVENTIVE MEDICINE, 2014, 64 : 108 - 113
  • [8] Self-Sampling as an Intervention to Promote Cervical Cancer Screening Among Women With HIV
    Murphy, Jeanne
    Mark, Hayley
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2016, 20 (04) : e63 - e63
  • [9] Acceptability of self-sampling for DNA methylation-based cervical cancer screening in Nigerian women
    Illah, Ojone
    Daru, Patrick
    Morhason-Bello, Imran
    Okunowo, Adeyemi
    Anorlu, Rose
    Sagay, Atiene
    Adewole, Isaac
    Widschwendter, Martin
    Olaitan, Adeola
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A186 - A187
  • [10] Women's perspectives on human papillomavirus self-sampling in the context of the UK cervical screening programme
    Williams, Denitza
    Davies, Myfanwy
    Fiander, Alison
    Farewell, Daniel
    Hillier, Sharon
    Brain, Kate
    HEALTH EXPECTATIONS, 2017, 20 (05) : 1031 - 1040